Review
Copyright ©The Author(s) 2017.
World J Transplant. Jun 24, 2017; 7(3): 161-178
Published online Jun 24, 2017. doi: 10.5500/wjt.v7.i3.161
Table 2 Biomarker candidates in the context of ischemia reperfusion injury and delayed graft function
SymbolGene descriptionCytoband
ACTA2Actin, alpha 2, smooth muscle, aorta10q23.31
UMODUromodulin16p12.3
LGALS3Lectin, galactoside-binding, soluble, 314q22.3
SAT1Spermidine/spermine N1-acetyltransferase 1Xp22.11
HAVCR1Hepatitis A virus cellular receptor 15q33.3
CXCL1Chemokine (C-X-C motif) ligand 14q13.3
ANXA2Annexin A215q22.2
S100A6S100 calcium binding protein A61q21.3
CYR61Cysteine rich angiogenic inducer 611p22.3
S100BS100 calcium binding protein B21q22.3
AMBPAlpha-1-microglobulin/bikunin precursor9q32
LCN2Lipocalin 29q34.11
C3Complement component 319p13.3
FABP1Fatty acid binding protein 1, liver2p11.2
ATF3Activating transcription factor 31q32.3
NTN1Netrin 117p13.1
ENGEndoglin9q34.11
GUCY2GGuanylate cyclase 2G10q25.2
BIDBH3 interacting domain death agonist22q11.21
BCL2B-Cell CLL/lymphoma 218q21.33
BAXBCL2 associated X protein19q13.33
PTGS2Prostaglandin-endoperoxide synthase 21q31.1
ADAMTS1ADAM metallopeptidase with thrombospondin type 1 motif 121q21.3
CDKN1ACyclin dependent kinase inhibitor 1A6p21.2